What is Regenxbio's other noncash income (expense)?

Regenxbio (RGNX) reported other noncash income (expense) of -$19K in Q1 2026.

How has Regenxbio's other noncash income (expense) changed year-over-year?

Regenxbio's other noncash income (expense) decreased by 290.0% year-over-year, from $10K to -$19K.

What does other noncash income (expense) mean?

This captures miscellaneous non-cash adjustments to net income that do not fit into standard categories like depreciation or stock-based compensation. It includes items such as changes in fair value of certain liabilities or non-cash impairment charges.

Regenxbio RGNX Other Noncash Income (Expense)

Other Noncash Income (Expense) at other companies

Regeneron PharmaceuticalsREGN

-$55.6M-1,638%

Sarepta Therapeutics, Inc.SRPT

$1.29M+394%

Ultragenyx PharmaceuticalRARE

-$1M-200%

Solid Biosciences Inc.SLDB

$0-100%

BiogenBIIB

——

BioMarin PharmaceuticalsBMRN

——

Other financials

Income statement

See full

Revenue$6.4M-92.8%

Gross profit$14.9M+35.7%

Operating income-$83.4M-787%

Net income-$90.1M-1,580%

EPS (diluted)-$1.72-1,533%

Balance sheet

See full

Cash & equivalents$15.2M-88.3%

Total debt$71.1M-11.0%

Total equity$21.1M-92.3%

Total assets$341.9M-30.4%

Cash flow

See full

Operating cash flow-$76.2M-327%

CapEx$1.2M+20.6%

Free cash flow-$77.4M-337%

Valuation

See full

Market cap$529.38M+24.6%

Enterprise value$585.22M+56.3%

P/S6×+3.3×

Profitability

See full

Gross margin59.7%+1.0pp

Operating margin-292.3%-613pp

Net margin-330.2%-588pp

FCF margin-269.2%-364pp

Returns & leverage

See full

Return on equity-196.4%-288pp

Debt / equity3.4×+3.1×

Current ratio2.6×-0.3×

Where this comes from

Reported directly by Regenxbio in its filing.

Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.

The official record: Regenxbio’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Regenxbio's other noncash income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Regenxbio's other noncash income (expense)?: Regenxbio (RGNX) reported other noncash income (expense) of -$19K in Q1 2026.
How has Regenxbio's other noncash income (expense) changed year-over-year?: Regenxbio's other noncash income (expense) decreased by 290.0% year-over-year, from $10K to -$19K.
What does other noncash income (expense) mean?: This captures miscellaneous non-cash adjustments to net income that do not fit into standard categories like depreciation or stock-based compensation. It includes items such as changes in fair value of certain liabilities or non-cash impairment charges.